1.Establishment and Practice of Information Management Platform for Cancer Pain and Chronic Pain Patients in Outpatient Department
Xiaoying GONG ; Jingjing MA ; Xun YU ; Jiao CHENG ; Xiaoxian ZHENG
China Pharmacy 2018;29(4):450-454
OBJECTIVE: To complete standardized management and follow-up for the cancer pain and chronic pain patients in outpatient department. METHODS: Information management platform was designed and established for cancer pain and chronic pain patients in outpatient department, including information entry, information inquiry, prompt for drug dispensing in advance, file unified management and regular scanning and removing excess medical records. The procedure of prescribing narcotic drugs for first visiting, subsequent visiting and follow-up patients was introduced. File management and prescription rationality before and after the establishment of information platform were compared. The adoption of pharmacist' s recommendation after the establishment of information platform were counted. RESULTS: Compared with before the establishment of information platform, the ratio of problematic profiles decreased from 42. 96% to 7. 06% (P<0. 05); the ratio of irrational prescription decreased from 4. 39% to 1. 19% (P<0. 05). Pharmacists provided a total of 1 542 recommendations for the patients with poor pain control and ADR. The adoption rate of the pharmaceutical recommendations was 63. 62%. CONCLUSIONS: The cancer pain and chronic pain information management platform can manage the outpatients' profile effectively and improve the rationality of the prescription. Meanwhile, the pharmacists have played an important role in the pain treatment for outpatients.
2.Advanced treatment time improves outcomes of patients with ischemic stroke undergoing reperfusion therapy.
Hongfang CHEN ; Xiaoxian GONG ; Dongjuan XU ; Zhimin WANG ; Haifang HU ; Chenglong WU ; Xiaoling ZHANG ; Xiaodong MA ; Yaxian WANG ; Haitao HU ; Min LOU ; Zhicai CHEN
Journal of Zhejiang University. Medical sciences 2019;48(3):247-253
OBJECTIVE:
To investigate the effect of treatment time on the outcome of patients with ischemic stroke undergoing reperfusion therapy.
METHODS:
The clinical data of 3229 ischemic stroke patients who received intravenous thrombolysis with or without arterial thrombolysis from 71 hospitals in Zhejiang province from June 2017 to September 2018 were retrospectively reviewed. The good outcome was defined as modified Rankin Scale (mRS) ≤ 2. Binary logistic regression analysis was used to investigate the association of door to needle time (DNT), or door to reperfusion time (DRT) with the outcomes in patients treated by intravenous thrombolysis or bridging arterial thrombolysis, respectively.
RESULTS:
Binary logistic regression showed that DNT (=0.994, 95%:0.991-0.997, <0.01) or DRT (=0.989, 95%:0.983-0.995, <0.01) were independently associated with good outcomes, respectively. Every hour decreases in DNT resulted in a 4.7%increased probability of functional independence (mRS 0-2) in patients treated by intravenous thrombolysis; Every hour decreases in DRT was associated with a 11.4%increased probability of functional independence in patients treated by intravenous thrombolysis with arterial thrombolysis.
CONCLUSIONS
Good outcomes are associated with lower DNT in ischemic stroke patients treated by intravenous thrombolysis or lower DRT in patients treated by intravenous thrombolysis bridging arterial thrombolysis.
Brain Ischemia
;
drug therapy
;
Fibrinolytic Agents
;
therapeutic use
;
Humans
;
Reperfusion
;
Retrospective Studies
;
Stroke
;
drug therapy
;
Thrombolytic Therapy
;
Time Factors
;
Treatment Outcome